Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 14

1.

An Update on Treatment of Drug-Induced Liver Injury.

Giordano C, Rivas J, Zervos X.

J Clin Transl Hepatol. 2014 Jun;2(2):74-9. doi: 10.14218/JCTH.2014.00005. Epub 2014 Jun 15. Review.

2.

Aspirin-Induced Acute Liver Injury.

Laster J, Satoskar R.

ACG Case Rep J. 2014 Oct 10;2(1):48-9. doi: 10.14309/crj.2014.81. eCollection 2014 Oct.

3.

Antimicrobial resistance: risk associated with antibiotic overuse and initiatives to reduce the problem.

Llor C, Bjerrum L.

Ther Adv Drug Saf. 2014 Dec;5(6):229-41. doi: 10.1177/2042098614554919. Review.

4.
5.

Khat (Catha Edulis) as a possible cause of autoimmune hepatitis.

Riyaz S, Imran M, Gleeson D, Karajeh MA.

World J Hepatol. 2014 Mar 27;6(3):150-4. doi: 10.4254/wjh.v6.i3.150.

6.

In vitro hepatic trans-differentiation of human mesenchymal stem cells using sera from congestive/ischemic liver during cardiac failure.

Bishi DK, Mathapati S, Cherian KM, Guhathakurta S, Verma RS.

PLoS One. 2014 Mar 18;9(3):e92397. doi: 10.1371/journal.pone.0092397. eCollection 2014.

7.

Prediction of clinically relevant safety signals of nephrotoxicity through plasma metabolite profiling.

Mattes WB, Kamp HG, Fabian E, Herold M, Krennrich G, Looser R, Mellert W, Prokoudine A, Strauss V, van Ravenzwaay B, Walk T, Naraoka H, Omura K, Schuppe-Koistinen I, Nadanaciva S, Bush ED, Moeller N, Ruiz-Noppinger P, Piccoli SP.

Biomed Res Int. 2013;2013:202497. doi: 10.1155/2013/202497. Epub 2013 May 21.

8.

Risk of oral antifungal agent-induced liver injury in Taiwanese.

Kao WY, Su CW, Huang YS, Chou YC, Chen YC, Chung WH, Hou MC, Lin HC, Lee FY, Wu JC.

Br J Clin Pharmacol. 2014 Jan;77(1):180-9. doi: 10.1111/bcp.12178.

9.

Jaundice following intravesical botulinum toxin - a previously unreported complication.

Marri RR, Bromage SJ, Darmalingum A, Calvert C, Banait G, Jones DA, Islam S.

BMJ Case Rep. 2010 Oct 28;2010. pii: bcr0420102881. doi: 10.1136/bcr.04.2010.2881. Review.

10.

Extended release niacin-laropiprant in patients with hypercholesterolemia or mixed dyslipidemias improves clinical parameters.

Vosper H.

Clin Med Insights Cardiol. 2011;5:85-101. doi: 10.4137/CMC.S7601. Epub 2011 Sep 19.

11.

Hepatic safety of antibiotics used in primary care.

Andrade RJ, Tulkens PM.

J Antimicrob Chemother. 2011 Jul;66(7):1431-46. doi: 10.1093/jac/dkr159. Epub 2011 May 17. Review.

12.

Statins in the treatment of dyslipidemia in the presence of elevated liver aminotransferase levels: a therapeutic dilemma.

Calderon RM, Cubeddu LX, Goldberg RB, Schiff ER.

Mayo Clin Proc. 2010 Apr;85(4):349-56. doi: 10.4065/mcp.2009.0365. Review.

13.

Circulating microRNAs, potential biomarkers for drug-induced liver injury.

Wang K, Zhang S, Marzolf B, Troisch P, Brightman A, Hu Z, Hood LE, Galas DJ.

Proc Natl Acad Sci U S A. 2009 Mar 17;106(11):4402-7. doi: 10.1073/pnas.0813371106. Epub 2009 Feb 25.

14.

Non invasive high resolution in vivo imaging of alpha-naphthylisothiocyanate (ANIT) induced hepatobiliary toxicity in STII medaka.

Hardman R, Kullman S, Yuen B, Hinton DE.

Aquat Toxicol. 2008 Jan 20;86(1):20-37. Epub 2007 Oct 6.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk